American Century Companies Inc Iveric Bio, Inc. Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$26.24 - $39.63 $93.6 Million - $141 Million
-3,565,655 Reduced 88.15%
479,263 $18.9 Million
Q1 2023

May 11, 2023
BUY
$18.67 - $24.56 $50.7 Million - $66.6 Million
2,713,544 Added 203.82%
4,044,918 $98.4 Million
Q4 2022

Feb 13, 2023
BUY
$17.24 - $23.95 $23 Million - $31.9 Million
1,331,374 New
1,331,374 $28.5 Million

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email